Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-34.1	-48.59	-36.79	-20.2	-20.54
Depreciation & Amortization	2.71	2.54	0.69	0.21	0.07
Share-Based Compensation	4.45	5.81	5.66	1.49	1.18
Other Operating Activities	-5.08	1.21	0.19	0.69	6.92
Operating Cash Flow	-32.02	-39.03	-30.26	-17.71	-8.57
Capital Expenditures	-0.01	-0.31	-1.71	-1.21	-0.05
Acquisitions	0	0	0	-0.2	0
Change in Investments	38.43	50.26	-141.41	0	0
Investing Cash Flow	38.41	49.95	-143.12	-1.4	-0.05
Share Issuance / Repurchase	-10.41	0.34	140.7	0.02	0.15
Debt Issued / Paid	-0.76	-0.63	-0.26	0.53	8.07
Other Financing Activities	-	-	23.49	34.91	-
Financing Cash Flow	-11.17	-0.29	163.94	35.45	8.22
Net Cash Flow	-4.78	10.64	-9.44	16.35	-0.4
Free Cash Flow	-32.04	-39.33	-31.97	-18.91	-8.62
Free Cash Flow Per Share	-1.15	-1.28	-1.15	-11.73	-23.48

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).